Evidence map›Paper›PMID 28424755›Full record

ArticleSensing and Bio-Sensing Research2017

Rapid, low cost prototyping of transdermal devices for personal healthcare monitoring.

Sanjiv Sharma, Anwer Saeed, Christopher Johnson, Nikolaj Gadegaard, Anthony Eg Cass

Open access · goldAbstract read
In one paragraph

Article in Sensing and Bio-Sensing Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 100 citations in OpenAlex.

  1. Review
  2. Review
  3. Can we still use the Michaelis-Menten model for enzymatic microneedle sensors?Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sanjiv SharmaDepartment of Chemistry & Institute of Biomedical Engineering, Exhibition Road, South Kensington Campus, Imperial College London, SW7 2AZ, UK.
Anwer SaeedSchool of Engineering, University of Glasgow, Glasgow G12 8LT, UK.
Christopher JohnsonDepartment of Chemistry & Institute of Biomedical Engineering, Exhibition Road, South Kensington Campus, Imperial College London, SW7 2AZ, UK.
Nikolaj GadegaardSchool of Engineering, University of Glasgow, Glasgow G12 8LT, UK.
Anthony Eg CassDepartment of Chemistry & Institute of Biomedical Engineering, Exhibition Road, South Kensington Campus, Imperial College London, SW7 2AZ, UK.
Imperial College London · GBUniversity of Glasgow · GB

Funding

Department of Health II-LA-0313-20004
6 · The paper itself

Abstract

The next generation of devices for personal healthcare monitoring will comprise molecular sensors to monitor analytes of interest in the skin compartment. Transdermal devices based on microneedles offer an excellent opportunity to explore the dynamics of molecular markers in the interstitial fluid, however good acceptability of these next generation devices will require several technical problems associated with current commercially available wearable sensors to be overcome. These particularly include reliability, comfort and cost. An essential pre-requisite for transdermal molecular sensing devices is that they can be fabricated using scalable technologies which are cost effective. We present here a minimally invasive microneedle array as a continuous monitoring platform technology. Method for scalable fabrication of these structures is presented. The microneedle arrays were characterised mechanically and were shown to penetrate human skin under moderate thumb pressure. They were then functionalised and evaluated as glucose, lactate and theophylline biosensors. The results suggest that this technology can be employed in the measurement of metabolites, therapeutic drugs and biomarkers and could have an important role to play in the management of chronic diseases.

Indexed as

Continuous glucose monitoring (CGM)Continuous lactate monitoring (CLM)Interstitial therapeutic drug monitoring (iTDM)MicroneedlesMinimally invasive sensors

Identifiers

PMID28424755
PMCPMC5384990
OpenAlexW2529894336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.